-
1
-
-
15744401773
-
Eukaryotic cytosine methyltransferases
-
DOI 10.1146/annurev.biochem.74.010904.153721
-
Goll, M. G. and Bestor, T. H. (2005) Eukaryotic cytosine methyltransferases Annu. Rev. Biochem. 74, 481-514 (Pubitemid 40995515)
-
(2005)
Annual Review of Biochemistry
, vol.74
, pp. 481-514
-
-
Goll, M.G.1
Bestor, T.H.2
-
2
-
-
0033615717
-
DNA methyltransferases Dnmt3a and Dnmt3b are essential for de novo methylation and mammalian development
-
DOI 10.1016/S0092-8674(00)81656-6
-
Okano, M., Bell, D. W., Haber, D. A., and Li, E. (1999) DNA methyltransferases Dnmt3a and Dnmt3b are essential for de novo methylation and mammalian development Cell 99, 247-257 (Pubitemid 29519904)
-
(1999)
Cell
, vol.99
, Issue.3
, pp. 247-257
-
-
Okano, M.1
Bell, D.W.2
Haber, D.A.3
Li, E.4
-
3
-
-
0026708177
-
Targeted mutation of the DNA methyltransferase gene results in embryonic lethality
-
Li, E., Bestor, T. H., and Jaenisch, R. (1992) Targeted mutation of the DNA methyltransferase gene results in embryonic lethality Cell 69, 915-926
-
(1992)
Cell
, vol.69
, pp. 915-926
-
-
Li, E.1
Bestor, T.H.2
Jaenisch, R.3
-
4
-
-
74049141478
-
Epigenetics in cancer
-
Sharma, S., Kelly, T. K., and Jones, P. A. (2010) Epigenetics in cancer Carcinogenesis 31, 27-36
-
(2010)
Carcinogenesis
, vol.31
, pp. 27-36
-
-
Sharma, S.1
Kelly, T.K.2
Jones, P.A.3
-
5
-
-
0345357773
-
Gene Silencing in Cancer in Association with Promoter Hypermethylation
-
DOI 10.1056/NEJMra023075
-
Herman, J. G. and Baylin, S. B. (2003) Gene silencing in cancer in association with promoter hypermethylation N. Engl. J. Med. 349, 2042-2054 (Pubitemid 37448928)
-
(2003)
New England Journal of Medicine
, vol.349
, Issue.21
, pp. 2042-2054
-
-
Herman, J.G.1
Baylin, S.B.2
-
6
-
-
0034652596
-
Gene promoter hypermethylation in tumors and serum of head and neck cancer patients
-
Sanchez-Cespedes, M., Esteller, M., Wu, L., Nawroz-Danish, H., Yoo, G. H., Koch, W. M., Jen, J., Herman, J. G., and Sidransky, D. (2000) Gene promoter hypermethylation in tumors and serum of head and neck cancer patients Cancer Res. 60, 892-895 (Pubitemid 30129522)
-
(2000)
Cancer Research
, vol.60
, Issue.4
, pp. 892-895
-
-
Sanchez-Cespedes, M.1
Esteller, M.2
Wu, L.3
Nawroz-Danish, H.4
Yoo, G.H.5
Koch, W.M.6
Jen, J.7
Herman, J.G.8
Sidransky, D.9
-
7
-
-
0035116695
-
6-methylguanine- DNA-methyltransferase, and death-associated protein kinase in tumors and saliva of head and neck cancer patients
-
Rosas, S. L. B., Koch, W., Carvalho, M. D. D., Wu, L., Califano, J., Westra, W., Jen, J., and Sidransky, D. (2001) Promoter hypermethylation patterns of p16, O-6-methylguanine-DNA-methyltransferase, and death-associated protein kinase in tumors and saliva of head and neck cancer patients Cancer Res. 61, 939-942 (Pubitemid 32174408)
-
(2001)
Cancer Research
, vol.61
, Issue.3
, pp. 939-942
-
-
Rosas, S.L.B.1
Koch, W.2
Da Costa Carvalho, M.D.G.3
Wu, L.4
Califano, J.5
Westra, W.6
Jen, J.7
Sidransky, D.8
-
8
-
-
0037093195
-
Randomized controlled trial of azacitidine in patients with the myelodysplastic syndrome: A study of the cancer and leukemia group B
-
DOI 10.1200/JCO.2002.04.117
-
Silverman, L. R., Demakos, E. P., Peterson, B. L., Kornblith, A. B., Holland, J. C., Odchimar-Reissig, R., Stone, R. M., Nelson, D., Powell, B. L., DeCastro, C. M., Ellerton, J., Larson, R. A., Schiffer, C. A., and Holland, J. F. (2002) Randomized controlled trial of azacitidine in patients with the myelodysplastic syndrome: A study of the cancer and leukemia group B J. Clin. Oncol. 20, 2429-2440 (Pubitemid 34525728)
-
(2002)
Journal of Clinical Oncology
, vol.20
, Issue.10
, pp. 2429-2440
-
-
Silverman, L.R.1
Demakos, E.P.2
Peterson, B.L.3
Kornblith, A.B.4
Holland, J.C.5
Odchimar-Reissig, R.6
Stone, R.M.7
Nelson, D.8
Powell, B.L.9
DeCastro, C.M.10
Ellerton, J.11
Larson, R.A.12
Schiffer, C.A.13
Holland, J.F.14
-
9
-
-
33646071894
-
Decitabine improves patient outcomes in myelodysplastic syndromes - Resuits of a Phase III randomized study
-
Kantarjian, H., Issa, J. P. J., Rosenfeld, C. S., Bennett, J. M., Albitar, M., DiPersio, J., Klimek, V., Slack, J., de Castro, C., Ravandi, F., Helmer, R., Shen, L. L., Nimer, S. D., Leavitt, R., Raza, A., and Saba, H. (2006) Decitabine improves patient outcomes in myelodysplastic syndromes-Resuits of a Phase III randomized study Cancer 106, 1794-1803
-
(2006)
Cancer
, vol.106
, pp. 1794-1803
-
-
Kantarjian, H.1
Issa, J.P.J.2
Rosenfeld, C.S.3
Bennett, J.M.4
Albitar, M.5
Dipersio, J.6
Klimek, V.7
Slack, J.8
De Castro, C.9
Ravandi, F.10
Helmer, R.11
Shen, L.L.12
Nimer, S.D.13
Leavitt, R.14
Raza, A.15
Saba, H.16
-
10
-
-
79952236603
-
6-Thioguanine reactivates epigenetically silenced genes in acute lymphoblastic leukemia cells by facilitating proteasome-mediated degradation of DNMT1
-
Yuan, B., Zhang, J., Wang, H., Xiong, L., Cai, Q., Wang, T., Jacobsen, S., Pradhan, S., and Wang, Y. (2011) 6-Thioguanine reactivates epigenetically silenced genes in acute lymphoblastic leukemia cells by facilitating proteasome-mediated degradation of DNMT1 Cancer Res. 71, 1904-1911
-
(2011)
Cancer Res.
, vol.71
, pp. 1904-1911
-
-
Yuan, B.1
Zhang, J.2
Wang, H.3
Xiong, L.4
Cai, Q.5
Wang, T.6
Jacobsen, S.7
Pradhan, S.8
Wang, Y.9
-
11
-
-
0024431109
-
Drug-induced DNA hypermethylation and drug resistance in human tumors
-
Nyce, J. (1989) Drug-induced DNA hypermethylation and drug-resistance in human-tumors Cancer Res. 49, 5829-5836 (Pubitemid 19274132)
-
(1989)
Cancer Research
, vol.49
, Issue.21
, pp. 5829-5836
-
-
Nyce, J.1
-
12
-
-
0035710746
-
-CT method
-
DOI 10.1006/meth.2001.1262
-
-δδCT Method Methods 25, 402-408 (Pubitemid 34164012)
-
(2001)
Methods
, vol.25
, Issue.4
, pp. 402-408
-
-
Livak, K.J.1
Schmittgen, T.D.2
-
13
-
-
65249102251
-
Regulation of DNMT1 stability through SET7-mediated lysine methylation in mammalian cells
-
Esteve, P. O., Chin, H. G., Benner, J., Feehery, G. R., Samaranayake, M., Horwitz, G. A., Jacobsen, S. E., and Pradhan, S. (2009) Regulation of DNMT1 stability through SET7-mediated lysine methylation in mammalian cells Proc. Natl. Acad. Sci. U.S.A. 106, 5076-5081
-
(2009)
Proc. Natl. Acad. Sci. U.S.A.
, vol.106
, pp. 5076-5081
-
-
Esteve, P.O.1
Chin, H.G.2
Benner, J.3
Feehery, G.R.4
Samaranayake, M.5
Horwitz, G.A.6
Jacobsen, S.E.7
Pradhan, S.8
-
14
-
-
64349105024
-
6-Thioguanine perturbs cytosine methylation at the CpG dinucleotide site by DNA methyltransferases in vitro and acts as a DNA demethylating agent in vivo
-
Wang, H. X. and Wang, Y. S. (2009) 6-Thioguanine perturbs cytosine methylation at the CpG dinucleotide site by DNA methyltransferases in vitro and acts as a DNA demethylating agent in vivo Biochemistry 48, 2290-2299
-
(2009)
Biochemistry
, vol.48
, pp. 2290-2299
-
-
Wang, H.X.1
Wang, Y.S.2
-
15
-
-
58149156264
-
The lysine demethylase LSD1 (KDM1) is required for maintenance of global DNA methylation
-
Wang, J., Hevi, S., Kurash, J. K., Lei, H., Gay, F., Bajko, J., Su, H., Sun, W., Chang, H., Xu, G., Gaudet, F., Li, E., and Chen, T. (2009) The lysine demethylase LSD1 (KDM1) is required for maintenance of global DNA methylation Nat. Genet. 41, 125-129
-
(2009)
Nat. Genet.
, vol.41
, pp. 125-129
-
-
Wang, J.1
Hevi, S.2
Kurash, J.K.3
Lei, H.4
Gay, F.5
Bajko, J.6
Su, H.7
Sun, W.8
Chang, H.9
Xu, G.10
Gaudet, F.11
Li, E.12
Chen, T.13
-
16
-
-
33644775686
-
Targeting multidrug resistance in cancer
-
DOI 10.1038/nrd1984, PII N1984
-
Szakacs, G., Paterson, J. K., Ludwig, J. A., Booth-Genthe, C., and Gottesman, M. M. (2006) Targeting multidrug resistance in cancer Nat. Rev. Drug Discovery 5, 219-234 (Pubitemid 43336035)
-
(2006)
Nature Reviews Drug Discovery
, vol.5
, Issue.3
, pp. 219-234
-
-
Szakacs, G.1
Paterson, J.K.2
Ludwig, J.A.3
Booth-Genthe, C.4
Gottesman, M.M.5
|